Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Pharmacological Reviews|February 12, 2014
G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectivesSergi Ferré, Vicent Casadó, Lakshmi A Devi, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Burkholderia cenocepacia epigenetic regulator M.BceJIV simultaneously engages two DNA recognition sequences for methylationRichard Quintana-Feliciano, Jithesh Kottur, Mi Ni, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 23, 2014
RUC-4: a novel αIIbβ3 antagonist for prehospital therapy of myocardial infarctionJihong Li, Spandana Vootukuri, Yi Shang, et al.
Elife|October 25, 2019
Structure-based characterization of novel TRPV5 inhibitorsTaylor Et Hughes, John Smith Del Rosario, Abhijeet Kapoor, et al.
Nature Communications|September 7, 2024
Burkholderia cenocepacia epigenetic regulator M.BceJIV simultaneously engages two DNA recognition sequences for methylationRichard Quintana-Feliciano, Jithesh Kottur, Mi Ni, et al.
Pharmacological Reviews|March 3, 2007
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimersJean-Philippe Pin, Richard Neubig, Michel Bouvier, et al.
Science Signaling|June 2, 2016
Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intakeJonathan H Wardman, Ivone Gomes, Erin N Bobeck, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013
Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activityIvone Gomes, Wakako Fujita, Achla Gupta, et al.
Journal of Chemical Information and Modeling|September 9, 2015
Ligand-Based Discovery of a New Scaffold for Allosteric Modulation of the μ-Opioid ReceptorPaola Bisignano, Neil T Burford, Yi Shang, et al.
Blood|May 6, 2009
Structural and therapeutic insights from the species specificity and in vivo antithrombotic activity of a novel alphaIIb-specific alphaIIbbeta3 antagonistRobert Blue, M Anna Kowalska, Jessica Hirsch, et al.
Pageof 13